ReviewFrontiers in pharmacology2026
Quercetin in bone regeneration: optimization of drug delivery system and study of its synergistic mechanism with bone tissue engineering.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skeletal diseases impose a heavy global burden, creating an urgent demand for safe and effective therapeutic strategies for bone regeneration. Quercetin, a natural flavonoid compound, has attracted considerable attention owing to its potential to promote bone formation and inhibit bone resorption. Nevertheless, its poor solubility and low bioavailability limit its clinical application. The integration of drug delivery systems with bone tissue engineering offers a promising approach to address these challenges. This review examines the latest advances in quercetin-based drug delivery systems and their synergistic mechanisms with bone tissue engineering. It systematically discusses various strategies, including hydrogels, hydroxyapatite, biofunctional scaffolds, phospholipid carriers, metal complexes, nanomaterials, and medicinal chemical modifications, and presents the core advantages of these approaches in achieving targeted delivery, controlled release, and enhanced bioactivity of quercetin. Furthermore, this review highlights the central role of these delivery systems in potentiating the pro-regenerative effects of quercetin. These advances not only provide practical solutions to overcome the inherent limitations of quercetin but also significantly broaden its application prospects in bone tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.